Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of permethrin cream versus metronidazole cream for papulopustular rosacea
2010-023566-43Phase 3Completed
- Sponsor
- InfectoPharm
- Start
- Nov 2011
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of permethrin and metronidazole in papulopustular rosacea and rosacea (3 arms), sponsored by InfectoPharm. Primary endpoint: Primary efficacy endpoint. Started Nov 2011; status: completed.
02
Drugs
permethrinmetronidazole
03
Conditions
papulopustular rosacearosacea
Beyond the preview
Go deeper on 2010-023566-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023566-43.